CD79A and myeloid sarcoma: The results indicate that the AUC values of PTPRC, CD19, CXCL8, CD79A, and IL7 effectively distinguish MS patients from the control group (Figure 4B), with values of 0.819, 0.862, 0.919, 0.848, and 0.910, respectively.